Case Report

Hyperprothrombinemia as a Result of a Possible Warfarin and Intravaginal Miconazole Interaction

Authors: Jeremy L. Thomas, PharmD, CDE, Donald Dunn, PharmD, Allen Pelletier, MD, Andrea S. Franks, PharmD, BCPS

Abstract

Warfarin, a commonly prescribed anticoagulant, has many potential drug interactions. We describe a case of intravaginal miconazole potentiating the effects of warfarin in a patient previously stable on a consistent dose of 8.5 mg warfarin daily. Following a course of intravaginal miconazole and a dosage increase to 9 mg daily, her international normalized ratio (INR) increased from 2.0 to 5. After the course of miconazole was complete, the patient was stable with a therapeutic INR (mean INR 2.9) on 9 mg warfarin daily. Clinicians should consider the possibility of systemic absorption of intravaginal miconazole, and a resultant increase in warfarin's anticoagulant effect.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Ansell J, Hirsh J, Hylek E, et al; American College of Chest Physicians. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th edition). Chest 2008;133(6 Suppl):160S–198S.
 
2. Wells PS, Holbrook AM, Crowther NR, et al. Interactions of warfarin with drugs and food. Ann Intern Med 1994;121:676–683.
 
3. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005;165:1095–1106.
 
4. Visser LE, Penning-van Beest FJ, Kasbergen AA, et al. Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulants. Clin Pharmacol Ther 2002;71:496–502.
 
5. Colquhoun MC, Daly M, Stewart P, et al. Interaction between warfarin and miconazole oral gel. Lancet 1987;1:695–696.
 
6. Pillans P, Woods DJ. Interaction between miconazole oral gel (Daktarin) and warfarin. N Z Med J 1996;109:346.
 
7. Thirion DJ, Zanetti LA. Potentiation of warfarin's hypoprothrombinemic effect with miconazole vaginal suppositories. Pharmacotherapy 2000;20:98–99.
 
8. Turrentine MA. Single-dose fluconazole for vulvovaginal candidiasis: impact on prothrombin time in women taking warfarin. Obstet Gynecol 2006;107:310–313.
 
9. FDA Safety Alerts for Human Medical Products: Miconzole [FDA website]. March 5, 2001. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts. Accessed December 17, 2009.